Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis
May 1, 2018, 00:00
10.1016/j.jval.2018.04.095
https://www.valueinhealthjournal.com/article/S1098-3015(18)30395-4/fulltext
Title :
Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30395-4&doi=10.1016/j.jval.2018.04.095
First page :
Section Title :
Open access? :
No
Section Order :
368